Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

A new pleosporalean fungus isolated from superficial to deep human clinical specimens.

PMID: 32717745
Journal: MEDICAL MYCOLOGY
Year: 2021
Reference: Med Mycol. 2021 Mar 4;59(3):278-288. doi: 10.1093/mmy/myaa055.
Impact factor:
Publication type: Paper in international publication
Authors: Cano-Lira, Jose F; Guarro, Josep; Los-Arcos, Ibai; Martin-Gomez, M Teresa; Stchigel, Alberto M; Valenzuela-Lopez, Nicomedes et al.
DOI: 10.1093/mmy/myaa055

A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.

PMID: 33423945
Journal: European Urology Oncology
Year: 2021
Reference: Eur Urol Oncol. 2021 Jun;4(3):464-472. doi: 10.1016/j.euo.2020.12.006. Epub 2021 Jan 7.
Impact factor: 7.479
Publication type: Paper in international publication
Authors: Shreck, Evan, Gartrell, Benjamin A, Sankin, Alex, Tripathi, Abhishek, Zakopoulou, Roubini, Bamias, Aristotelis, Rodriguez-Vida, Alejo, Drakaki, Alexandra, Liu, Sandy, Kumar, Vivek et al.
DOI: 10.1016/j.euo.2020.12.006

A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.

PMID: 33423945
Journal: European Urology Oncology
Year: 2021
Reference: Eur Urol Oncol. 2021 Jun;4(3):464-472. doi: 10.1016/j.euo.2020.12.006. Epub 2021 Jan 7.
Impact factor:
Publication type: Paper in international publication
Authors: Agarwal, Neeraj; Alonso Buznego, Lucia; Alva, Ajjai; Bamias, Aristotelis; Barata, Pedro; Bilen, Mehmet A; Carril-Ajuria, Lucia; Castellano, Daniel; De Kouchkovsky, Ivan; Devitt, Michael et al.
DOI: 10.1016/j.euo.2020.12.006

A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project.

PMID: 33205902
Journal: PEDIATRIC BLOOD & CANCER
Year: 2021
Reference: Pediatr Blood Cancer. 2021 Mar;68(3):e28794. doi: 10.1002/pbc.28794. Epub 2020 Nov 18.
Impact factor: 3.167
Publication type: Paper in international publication
Authors: Irwin, Meredith S, Berthold, Frank, Hogarty, Michael, Kamijo, Takehiko, Morgenstern, Daniel, Pasqualini, Claudia, Ash, Shifra, Potschger, Ulrike, Ladenstein, Ruth, Valteau-Couanet, Dominique et al.
DOI: 10.1002/pbc.28794

A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project.

PMID: 33205902
Journal: PEDIATRIC BLOOD & CANCER
Year: 2021
Reference: Pediatr Blood Cancer. 2021 Mar;68(3):e28794. doi: 10.1002/pbc.28794. Epub 2020 Nov 18.
Impact factor:
Publication type: Paper in international publication
Authors: Ash, Shifra; Berthold, Frank; Cohn, Susan L; Guo, Dongjing; Hogarty, Michael; Irwin, Meredith S; Kamijo, Takehiko; Ladenstein, Ruth; London, Wendy B; Moreno, Lucas et al.
DOI: 10.1002/pbc.28794

A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement.

PMID: 33746085
Journal: JOURNAL OF HEPATOLOGY
Year: 2021
Reference: J Hepatol. 2021 Aug;75(2):275-283. doi: 10.1016/j.jhep.2021.02.033. Epub 2021 Mar 18.
Impact factor: 25.083
Publication type: Paper in international publication
Authors: Pose, Elisa, Torrents, Abiguei, Reverter, Enric, Perez-Campuzano, Valeria, Campos-Varela, Isabel, Avitabile, Emma, Gratacos-Gines, Jordi, Castellote, Jose, Colmenero, Jordi, Tort, Jaume et al.
DOI: 10.1016/j.jhep.2021.02.033

A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement.

PMID: 33746085
Journal: JOURNAL OF HEPATOLOGY
Year: 2021
Reference: J Hepatol. 2021 Aug;75(2):275-283. doi: 10.1016/j.jhep.2021.02.033. Epub 2021 Mar 18.
Impact factor:
Publication type: Paper in international publication
Authors: Avitabile, Emma; Campos-Varela, Isabel; Castellote, Jose; Castells, Lluis; Colmenero, Jordi; Crespo, Gonzalo; Gines, Pere; Gratacos-Gines, Jordi; Perez-Campuzano, Valeria; Pose, Elisa et al.
DOI: 10.1016/j.jhep.2021.02.033

A novel antagonistic CD73 antibody for inhibition of the immunosuppressive adenosine pathway.

PMID: 34482286
Journal: MOLECULAR CANCER THERAPEUTICS
Year: 2021
Reference: Mol Cancer Ther. 2021 Nov;20(11):2250-2261. doi: 10.1158/1535-7163.MCT-21-0107. Epub 2021 Sep 4.
Impact factor:
Publication type: Paper in international publication
Authors: Adam, Paul J; Alt, Isabella; Auguste, Aurelie; Bottcher, Jark; Capdevila, Jaume; de Andrade Pereira, Bruna; Delic, Denis; Ganesan, Rajkumar; Han, Fei; Hofmann, Irmgard et al.
DOI: 10.1158/1535-7163.MCT-21-0107

A novel case of diabetes MODY1 and chronic hereditary pancreatitis: coexistence of two infrequent genetic mutations.

PMID: 33846082
Journal: Endocrinologia Diabetes y Nutricion
Year: 2021
Reference: Endocrinol Diabetes Nutr (Engl Ed). 2021 Apr 9. pii: S2530-0164(21)00077-X. doi: 10.1016/j.endinu.2020.11.008.
Impact factor: 1.417
Publication type: Letter or abstract
Authors: Cordero-Vazquez, Efrain, Filippi-Arriaga, Francesca, Hernandez, Irene Hernandez, Haman, Stephanie Solange Tasayco, Ciudin, Andreea et al.
DOI: 10.1016/j.endinu.2020.11.008

A novel experimental porcine model to assess the impact of differential pulmonary blood flow on ischemia-reperfusion injury after unilateral lung transplantation.

PMID: 33543363
Journal: Intensive care medicine experimental
Year: 2021
Reference: Intensive Care Med Exp. 2021 Feb 5;9(1):4. doi: 10.1186/s40635-021-00371-1.
Impact factor:
Publication type: Paper in international publication
Authors: Claes, Sandra; Frick, Anna Elisabeth; Heigl, Tobias; Kaes, Janne; Neyrinck, Arne P; Ordies, Sofie; Orlitova, Michaela; Saez-Gimenez, Berta; Schols, Dominique; Van Raemdonck, Dirk E et al.
DOI: 10.1186/s40635-021-00371-1

A novel model of care for simplified testing of HBV in African communities during the COVID-19 pandemic in Spain.

PMID: 34433852
Journal: Scientific Reports
Year: 2021
Reference: Sci Rep. 2021 Aug 25;11(1):17063. doi: 10.1038/s41598-021-96350-3.
Impact factor: 4.38
Publication type: Paper in international publication
Authors: Picchio, Camila A, Nomah, Daniel K, Araujo, Silvia G, Rando-Segura, Ariadna, Fernandez, Emma, Buti, Maria, Rodriguez-Tajes, Sergio, Lens, Sabela, Rodriguez-Frias, Francisco, Lazarus, Jeffrey V et al.
DOI: 10.1038/s41598-021-96350-3

A novel model of care for simplified testing of HBV in African communities during the COVID-19 pandemic in Spain.

PMID: 34433852
Journal: Scientific Reports
Year: 2021
Reference: Sci Rep. 2021 Aug 25;11(1):17063. doi: 10.1038/s41598-021-96350-3.
Impact factor:
Publication type: Paper in international publication
Authors: Araujo, Silvia G; Buti, Maria; Fernandez, Emma; Lazarus, Jeffrey V; Lens, Sabela; Nomah, Daniel K; Picchio, Camila A; Rando-Segura, Ariadna; Rodriguez-Frias, Francisco; Rodriguez-Tajes, Sergio et al.
DOI: 10.1038/s41598-021-96350-3

A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse Events.

PMID: 34515215
Journal: Oncology Research and Treatment
Year: 2021
Reference: Oncol Res Treat. 2021;44(10):547-556. doi: 10.1159/000518549. Epub 2021 Aug 19.
Impact factor:
Publication type: Paper in international publication
Authors: Ando, Yuichi; Bialucha, Carl U; Concin, Nicole; DiDominick, Sarah; Faris, Jason E; Mansfield, Keith; Origuchi, Shizuka; Ruan, Shiling; Schoffski, Patrick; Suarez, Cristina et al.
DOI: 10.1159/000518549

A phase 1b study of the Notch inhibitor crenigacestat (LY3039478) in combination with other anticancer target agents (taladegib, LY3023414, or abemaciclib) in patients with advanced or metastatic solid tumors.

PMID: 33686452
Journal: INVESTIGATIONAL NEW DRUGS
Year: 2021
Reference: Invest New Drugs. 2021 Aug;39(4):1089-1098. doi: 10.1007/s10637-021-01094-6. Epub 2021 Mar 8.
Impact factor: 3.85
Publication type: Paper in international publication
Authors: Azaro, Analia, Massard, Christophe, Tap, William D, Cassier, Philippe A, Merchan, Jaime, Italiano, Antoine, Anderson, Bailey, Yuen, Eunice, Yu, Danni, Oakley, Gerard 3rd et al.
DOI: 10.1007/s10637-021-01094-6

A phase 1b study of the Notch inhibitor crenigacestat (LY3039478) in combination with other anticancer target agents (taladegib, LY3023414, or abemaciclib) in patients with advanced or metastatic solid tumors.

PMID: 33686452
Journal: INVESTIGATIONAL NEW DRUGS
Year: 2021
Reference: Invest New Drugs. 2021 Aug;39(4):1089-1098. doi: 10.1007/s10637-021-01094-6. Epub 2021 Mar 8.
Impact factor:
Publication type: Paper in international publication
Authors: Anderson, Bailey; Azaro, Analia; Benhadji, Karim A; Cassier, Philippe A; Italiano, Antoine; Massard, Christophe; Merchan, Jaime; Oakley, Gerard 3rd; Pant, Shubham; Tap, William D et al.
DOI: 10.1007/s10637-021-01094-6

A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures.

PMID: 33998885
Journal: Cannabis and Cannabinoid Research
Year: 2021
Reference: Cannabis Cannabinoid Res. 2021 Dec;6(6):528-536. doi: 10.1089/can.2020.0075. Epub 2021 Feb 15.
Impact factor: 5.8
Publication type: Paper in international publication
Authors: Toledo, Manuel, Brodie, Martin J, Czapinski, Piotr, Pazdera, Ladislav, Sander, Josemir W, Schreiber, Ashley, Nezadal, Tomas, Slonkova, Jana, Altman, Anna, Fule, Kalman et al.
DOI: 10.1089/can.2020.0075

A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures.

PMID: 33998885
Journal: Cannabis and Cannabinoid Research
Year: 2021
Reference: Cannabis Cannabinoid Res. 2021 Dec;6(6):528-536. doi: 10.1089/can.2020.0075. Epub 2021 Feb 15.
Impact factor:
Publication type: Paper in international publication
Authors: Altman, Anna; Bagary, Manny; Banach, Marta; Brodie, Martin J; Czapinski, Piotr; Falip, Merce; Fule, Kalman; Horvath, Agnes; Kelemen, Anna; Komoly, Samuel et al.
DOI: 10.1089/can.2020.0075

A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.

PMID: 33626197
Journal: CANCER
Year: 2021
Reference: Cancer. 2021 Jun 15;127(12):2003-2014. doi: 10.1002/cncr.33403. Epub 2021 Feb 24.
Impact factor: 6.86
Publication type: Paper in international publication
Authors: Serrano, Alfons, Labrador, Jorge, Sayas, Maria J, Foncillas, Maria A, Amador Barciela, Maria L, Olave, Maria Teresa, Colorado, Mercedes, Gascon, Adriana, Fernandez, Maria A, Simiele, Adriana et al.
DOI: 10.1002/cncr.33403

A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.

PMID: 33626197
Journal: CANCER
Year: 2021
Reference: Cancer. 2021 Jun 15;127(12):2003-2014. doi: 10.1002/cncr.33403. Epub 2021 Feb 24.
Impact factor:
Publication type: Paper in international publication
Authors: Algarra, Lorenzo; Amador Barciela, Maria L; Barragan, Eva; Bergua Burgues, Juan; Colorado, Mercedes; Falantes, Jose F; Fernandez, Maria A; Foncillas, Maria A; Garcia, Olga; Gascon, Adriana et al.
DOI: 10.1002/cncr.33403

A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors.

PMID: 33627685
Journal: Scientific Reports
Year: 2021
Reference: Sci Rep. 2021 Feb 24;11(1):4433. doi: 10.1038/s41598-021-82671-w.
Impact factor: 4.38
Publication type: Paper in international publication
Authors: Poveda, Andres, Oaknin, Ana, Romero, Ignacio, Guerrero-Zotano, Angel, Farinas-Madrid, Lorena, Rodriguez-Freixinos, Victor, Mallol, Pedro, Lopez-Reig, Raquel, Lopez-Guerrero, Jose Antonio et al.
DOI: 10.1038/s41598-021-82671-w

A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors.

PMID: 33627685
Journal: Scientific Reports
Year: 2021
Reference: Sci Rep. 2021 Feb 24;11(1):4433. doi: 10.1038/s41598-021-82671-w.
Impact factor:
Publication type: Paper in international publication
Authors: Farinas-Madrid, Lorena; Guerrero-Zotano, Angel; Lopez-Guerrero, Jose Antonio; Lopez-Reig, Raquel; Mallol, Pedro; Oaknin, Ana; Poveda, Andres; Rodriguez-Freixinos, Victor; Romero, Ignacio et al.
DOI: 10.1038/s41598-021-82671-w

A Phase I study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study).

PMID: 33067614
Journal: BLOOD
Year: 2021
Reference: Blood. 2021 Mar 25;137(12):1582-1590. doi: 10.1182/blood.2020007848.
Impact factor: 23.629
Publication type: Paper in international publication
Authors: Brivio, Erica, Locatelli, Franco, Lopez-Yurda, Marta, Malone, Andrea, Diaz de Heredia, Cristina, Bielorai, Bella, Rossig, Claudia, van der Velden, Vincent H J, Ammerlaan, Anneke Cj, Thano, Adriana et al.
DOI: 10.1182/blood.2020007848

A Phase I study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study).

PMID: 33067614
Journal: BLOOD
Year: 2021
Reference: Blood. 2021 Mar 25;137(12):1582-1590. doi: 10.1182/blood.2020007848.
Impact factor:
Publication type: Paper in international publication
Authors: Ammerlaan, Anneke Cj; Bielorai, Bella; Brethon, Benoit; Brivio, Erica; Chen, Ying; Chen-Santel, Christiane; Den Boer, Monique L; Diaz de Heredia, Cristina; Locatelli, Franco; Lopez-Yurda, Marta et al.
DOI: 10.1182/blood.2020007848

A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation.

PMID: 34169246
Journal: JHEP reports : innovation in hepatology
Year: 2021
Reference: JHEP Rep. 2021 Apr 18;3(4):100291. doi: 10.1016/j.jhepr.2021.100291. eCollection 2021 Aug.
Impact factor: 0
Publication type: Paper in international publication
Authors: Gordillo, Noelia, Vainilovich, Yelena, Barthel, Virginie, Clerget-Chossat, Nathalie, Sokal, Etienne M, Stoykov, Ivaylo, Michel, Sebastien, Najimi, Mustapha, Albillos, Agustin, Nevens, Frederik et al.
DOI: 10.1016/j.jhepr.2021.100291